Pulished Date October, 2018
ID: 1129
Share on
Share on

Latin America Autoimmune Diagnostics Market By Test Type - (Autoantibody Tests, Antinuclear Antibody Tests, Complete Blood Count (CBC), C - Reactive Protein (CRP), Comprehensive Metabolic Panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) And Others), By Disease - (Localized Auto Immune Disease Diagnostics (Graves’ Disease, Hashimoto's Thyroiditis, Type 1 Diabetes, Multiple Sclerosis, Psoriasis And Others), Systemic Auto Immune Disease Diagnostics(Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Ankylosing Spondylitis)) By End Users - (Hospitals, Research Centres, Diagnost

Pulished: October, 2018
ID: 1129
Pages: 134

Latin America Autoimmune Diagnostics Market was worth USD 1.69 billion in 2018 and estimated to reach USD 2.01 billion by the end of 2023 with a growing potential of 3.58%.

Autoimmune diseases are a hyper active immune response against its own body tissues and cells. Introduction of advanced technologies through mergers & acquisitions into the market play a key role in cure and treatment of auto immune diseases.

Increasing occurrence of auto immune disorders, high disposable income, increasing public awareness, improving healthcare infrastructure are the major factors driving the growth of the market. The key restraints that inhibiting the growth of the auto immune diagnostics market are high cost of treatment, unavailability of skilled labour and growing rate of diagnostics errors.

The Latin America Auto immune diagnostics Market is broadly categorized based on Test type into Complete Blood Count (CBC), Autoantibody Tests, Antinuclear Antibody Tests, C - reactive protein (CRP), Comprehensive Metabolic panel, Urinalysis, Erythrocyte Sedimentation Rate (ESR) and others.

Based on Disease type the market is categorized into Localized auto immune disease diagnostics and systemic auto immune disease diagnostics. Local auto immune disease diagnostics is further classified into Graves’ disease, Hashimoto's Thyroiditis, Type 1 diabetes, Multiple Sclerosis, Psoriasis and Others. Systemic auto immune disease diagnostics is categorized into Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and Ankylosing Spondylitis.

Based on End users into Hospitals, Research centres, and diagnostic laboratories and on the basis of geography, the Latin America Auto Immune Diagnostics market is analysed under various regions namely Mexico, brazil, Argentina and others.

Major players influencing the Latin America Autoimmune diagnostics market are Bio-Rad, Siemens Healthcare, Abbott Laboratories, Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics, INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics, Quest Diagnostics, Eli lilly, Glaxosmithkline Plc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Test Type                              

                                5.1.1 Autoantibody Tests             

                                5.1.2 Antinuclear Antibody Tests              

                                5.1.3 Complete Blood Count (CBC)          

                                5.1.4 C - reactive protein (CRP) 

                                5.1.5 Comprehensive Metabolic panel   

                                5.1.6 Urinalysis 

                                5.1.7 Erythrocyte Sedimentation Rate (ESR)        

                                5.1.8 Others      

                5.2 By Disease Type                       

                                5.2.1 Localized auto immune disease diagnostics              

                                                5.2.1.1 Graves' Disease

                                                5.2.1.2 Hashimoto's Thyroiditis

                                                5.2.1.3 Multiple Sclerosis

                                                5.2.1.4 Type 1 diabetes

                                                5.2.1.5 Psoriasis

                                                5.2.1.6 Others

                                5.2.2 Systemic auto immune disease diagnostics

                                                5.2.2.1 Rheumatoid Arthritis (RA)

                                                5.2.2.2 Ankylosing Spondylitis

                                                5.2.2.3 Systemic Lupus Erythematosus (SLE)

                5.3 By End Users                             

                                5.3.1 Hospitals  

                                "5.3.2 Research centers

 

"             

                                5.3.3 Diagnostic laboratories      

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 Brazil             

                                6.3 Mexico         

                                6.4 Rest of Latin America             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bio-Rad                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Siemens Healthcare                

                8.3 Abbott Laboratories               

                8.4 Crescendo Bioscience                            

                8.5 Roche Diagnostics                    

                8.6 SQI Diagnostics                         

                8.7 AESKU Diagnostics                   

                8.8 INOVA Diagnostics                  

                8.9 BioMerieux SA                          

                8.10 Beckman Coulter Inc.                           

                8.11 Hemagen Diagnostics                          

                8.12 Quest Diagnostics                  

                8.13 Eli lilly                         

                8.14 Glaxosmithkline Plc                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Latin America Autoimmune diagnostics Market By Region, From 2018-2023 (USD Billion)
  2. Latin America Autoimmune diagnostics Market By Test Type, From 2018-2023 (USD Billion)
  3. Latin America Autoantibody Tests Market By Region, From 2018-2023 (USD Billion)
  4. Latin America Antinuclear Antibody Tests Market By Region, From 2018-2023 (USD Billion)
  5. Latin America Complete Blood Count (CBC) Market By Region, From 2018-2023 (USD Billion)
  6. Latin America C - reactive protein (CRP) Market By Region, From 2018-2023 (USD Billion)
  7. Latin America Comprehensive Metabolic panel Market By Region, From 2018-2023 (USD Billion)
  8. Latin America Urinalysis Market By Region, From 2018-2023 (USD Billion)
  9. Latin America Erythrocyte Sedimentation Rate (ESR) Market By Region, From 2018-2023 (USD Billion)
  10. Latin America Other Test Types Market By Region, From 2018-2023 (USD Billion)
  11. Latin America Autoimmune diagnostics Market By Disease Type, From 2018-2023 (USD Billion)
  12. Latin America Localized Autoimmune Diseases Diagnostics Market By Region, From 2018-2023 (USD Billion)
  13. Latin America Systemic Autoimmune Diseases Diagnostics Market By Region, From 2018-2023 (USD Billion)
  14. Brazil Autoimmune diagnostics Market By Test Type, From 2018-2023 (USD Billion)
  15. Brazil Autoimmune diagnostics Market By Disease Type, From 2018-2023 (USD Billion)
  16. Argentina Autoimmune diagnostics Market By Test Type, From 2018-2023 (USD Billion)
  17. Argentina Autoimmune diagnostics Market By Disease Type, From 2018-2023 (USD Billion)
  18. Mexico Autoimmune diagnostics Market By Test Type, From 2018-2023 (USD Billion)
  19. Mexico Autoimmune diagnostics Market By Disease Type, From 2018-2023 (USD Billion)
  20. Latin America Localized Autoimmune Disease Diagnostics Market By Type, From 2018-2023 (USD Billion)
  21. Latin America Graves' Disease Market By Region, From 2018-2023 (USD Billion)
  22. Latin America Hashimoto's Thyroiditis Market By Region, From 2018-2023 (USD Billion)
  23. Latin America Multiple Sclerosis Market By Region, From 2018-2023 (USD Billion)
  24. Latin America Type 1 diabetes Market By Region, From 2018-2023 (USD Billion)
  25. Latin America Psoriasis Market By Region, From 2018-2023 (USD Billion)
  26. Latin America Other Localized Autoimmune Diagnostics Market By Region, From 2018-2023 (USD Billion)
  27. Brazil Localized Autoimmune Disease Diagnostics Market By Type, From 2018-2023 (USD Billion)
  28. Argentina Localized Autoimmune Disease Diagnostics Market By Type, From 2018-2023 (USD Billion)
  29. Mexico Localized Autoimmune Disease Diagnostics Market By Type, From 2018-2023 (USD Billion)
  30. Latin America Systemic Auto-immune disease diagnostics Market By Type, From 2018-2023 (USD Billion)
  31. Latin America Rheumatoid Arthritis (RA) Market By Region, From 2018-2023 (USD Billion)
  32. Latin America Ankylosing Spondylitis Market By Region, From 2018-2023 (USD Billion)
  33. Latin America Systemic Lupus Erythematosus (SLE) Market By Region, From 2018-2023 (USD Billion)
  34. Brazil Systemic Auto-immune disease diagnostics Market By Type, From 2018-2023 (USD Billion)
  35. Argentina Systemic Auto-immune disease diagnostics Market By Type, From 2018-2023 (USD Billion)
  36. Mexico Systemic Auto-immune disease diagnostics Market By Type, From 2018-2023 (USD Billion)

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients